1 in 3 Americans
have Non-Alcoholic Fatty Liver Disease (NAFLD) or Non-Alcoholic Steatohepatitis (NASH)
…and many of them may not know it.
Tampa Bay Medical Research uses Fibroscan as an alternative to liver biopsy to detect and stage Fatty Liver Disease. It is an ultrasound-based imaging tool that captures liver stiffness and scarring caused by fatty deposits in the liver.
Fibroscan is a painless, non-invasive procedure that requires no sedation and can be completed in just a few minutes. It enables our providers to screen patients for Fatty Liver Disease during their visit.